^
Phase 1/2
Hoffmann-La Roche
Recruiting
Last update posted :
02/10/2025
Initiation :
11/01/2020
Primary completion :
12/31/2026
Completion :
12/31/2026
PD-L1
|
Avastin (bevacizumab) • Tecentriq (atezolizumab) • amezalpat (TPST-1120) • Actemra IV (tocilizumab) • tiragolumab (RG6058) • IO-108 • NKT2152 • SAR439459 • muzastotug (ADG126) • tobemstomig (RG6139)